The fatty acid oxidation resulting from the dyslipidemia can upregulate the content of TG in the liver, while the hyperactivation of the JNK pathway contributes to the development of hepatic steatosis, obesity, and insulin resistance [11]. Here, MAPK8 is linked to Hepatic steatosis.